243 related articles for article (PubMed ID: 32532513)
1. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.
Lebastchi AH; George AK; Polascik TJ; Coleman J; de la Rosette J; Turkbey B; Wood BJ; Gorin MA; Sidana A; Ghai S; Tay KJ; Ward JF; Sanchez-Salas R; Muller BG; Malavaud B; Mozer P; Crouzet S; Choyke PL; Ukimura O; Rastinehad AR; Pinto PA
Eur Urol; 2020 Sep; 78(3):371-378. PubMed ID: 32532513
[TBL] [Abstract][Full Text] [Related]
2. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Fütterer JJ; Ghai S; Pinto PA; Popeneciu IV; de Reijke TM; Robertson C; de la Rosette JJ; Scionti S; Turkbey B; Wijkstra H; Ukimura O; Polascik TJ
World J Urol; 2015 Oct; 33(10):1503-9. PubMed ID: 25559111
[TBL] [Abstract][Full Text] [Related]
3. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.
Scheltema MJ; Tay KJ; Postema AW; de Bruin DM; Feller J; Futterer JJ; George AK; Gupta RT; Kahmann F; Kastner C; Laguna MP; Natarajan S; Rais-Bahrami S; Rastinehad AR; de Reijke TM; Salomon G; Stone N; van Velthoven R; Villani R; Villers A; Walz J; Polascik TJ; de la Rosette JJMCH
World J Urol; 2017 May; 35(5):695-701. PubMed ID: 27637908
[TBL] [Abstract][Full Text] [Related]
4. Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.
van den Bos W; Muller BG; Ahmed H; Bangma CH; Barret E; Crouzet S; Eggener SE; Gill IS; Joniau S; Kovacs G; Pahernik S; de la Rosette JJ; Rouvière O; Salomon G; Ward JF; Scardino PT
Eur Urol; 2014 Jun; 65(6):1078-83. PubMed ID: 24444476
[TBL] [Abstract][Full Text] [Related]
5. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
[TBL] [Abstract][Full Text] [Related]
6. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.
van Luijtelaar A; Greenwood BM; Ahmed HU; Barqawi AB; Barret E; Bomers JGR; Brausi MA; Choyke PL; Cooperberg MR; Eggener S; Feller JF; Frauscher F; George AK; Hindley RG; Jenniskens SFM; Klotz L; Kovacs G; Lindner U; Loeb S; Margolis DJ; Marks LS; May S; Mcclure TD; Montironi R; Nour SG; Oto A; Polascik TJ; Rastinehad AR; De Reyke TM; Reijnen JS; de la Rosette JJMCH; Sedelaar JPM; Sperling DS; Walser EM; Ward JF; Villers A; Ghai S; Fütterer JJ
World J Urol; 2019 Oct; 37(10):2147-2153. PubMed ID: 30671638
[TBL] [Abstract][Full Text] [Related]
7. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.
von Hardenberg J; Borkowetz A; Siegel F; Kornienko K; Westhoff N; Jordan TB; Hoffmann M; Drerup M; Lieb V; Taymoorian K; Schostak M; Ganzer R; Höfner T; Cash H; Bruendl J;
Eur Urol Focus; 2021 Sep; 7(5):1002-1010. PubMed ID: 33877047
[TBL] [Abstract][Full Text] [Related]
8. Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design.
van den Bos W; Muller BG; de Bruin DM; de Castro Abreu AL; Chaussy C; Coleman JA; Finelli A; Gill IS; Gross ME; Jenniskens SF; Kahmann F; Laguna-Pes MP; Rastinehad AR; Simmons LA; Sulser T; Villers A; Ward JF; de la Rosette JJ
Urol Oncol; 2015 Nov; 33(11):495.e1-7. PubMed ID: 26231310
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
10. Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.
Villers A; Puech P; Flamand V; Haber GP; Desai MM; Crouzet S; Leroy X; Chopra S; Lemaitre L; Ouzzane A; Gill IS
Eur Urol; 2017 Sep; 72(3):333-342. PubMed ID: 27613061
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis.
Bhat KRS; Covas Moschovas M; Sandri M; Noel J; Reddy S; Perera R; Rogers T; Roof S; Patel VR
Eur Urol Focus; 2022 Sep; 8(5):1192-1197. PubMed ID: 34736871
[TBL] [Abstract][Full Text] [Related]
12. Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.
Postema AW; De Reijke TM; Ukimura O; Van den Bos W; Azzouzi AR; Barret E; Baumunk D; Blana A; Bossi A; Brausi M; Coleman JA; Crouzet S; Dominguez-Escrig J; Eggener S; Ganzer R; Ghai S; Gill IS; Gupta RT; Henkel TO; Hohenfellner M; Jones JS; Kahmann F; Kastner C; Köhrmann KU; Kovacs G; Miano R; van Moorselaar RJ; Mottet N; Osorio L; Pieters BR; Polascik TJ; Rastinehad AR; Salomon G; Sanchez-Salas R; Schostak M; Sentker L; Tay KJ; Varkarakis IM; Villers A; Walz J; De la Rosette JJ
World J Urol; 2016 Oct; 34(10):1373-82. PubMed ID: 26892160
[TBL] [Abstract][Full Text] [Related]
13. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.
Tay KJ; Scheltema MJ; Ahmed HU; Barret E; Coleman JA; Dominguez-Escrig J; Ghai S; Huang J; Jones JS; Klotz LH; Robertson CN; Sanchez-Salas R; Scionti S; Sivaraman A; de la Rosette J; Polascik TJ
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):294-299. PubMed ID: 28349978
[TBL] [Abstract][Full Text] [Related]
14. Oncological control following partial gland ablation for intermediate-risk prostate cancer.
Becher E; Lepor H
Urol Oncol; 2020 Aug; 38(8):671-677. PubMed ID: 32487352
[TBL] [Abstract][Full Text] [Related]
15. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
Ahmed HU; Akin O; Coleman JA; Crane S; Emberton M; Goldenberg L; Hricak H; Kattan MW; Kurhanewicz J; Moore CM; Parker C; Polascik TJ; Scardino P; van As N; Villers A;
BJU Int; 2012 Jun; 109(11):1636-47. PubMed ID: 22077593
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
Donaldson IA; Alonzi R; Barratt D; Barret E; Berge V; Bott S; Bottomley D; Eggener S; Ehdaie B; Emberton M; Hindley R; Leslie T; Miners A; McCartan N; Moore CM; Pinto P; Polascik TJ; Simmons L; van der Meulen J; Villers A; Willis S; Ahmed HU
Eur Urol; 2015 Apr; 67(4):771-7. PubMed ID: 25281389
[TBL] [Abstract][Full Text] [Related]
18. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
19. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Tan WP; Rastinehad AR; Klotz L; Carroll PR; Emberton M; Feller JF; George AK; Gill IS; Gupta RT; Katz AE; Lebastchi AH; Marks LS; Marra G; Pinto PA; Song DY; Sidana A; Ward JF; Sanchez-Salas R; Rosette J; Polascik TJ;
Urol Oncol; 2021 Nov; 39(11):781.e17-781.e24. PubMed ID: 33676851
[TBL] [Abstract][Full Text] [Related]
20. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
